search icon

    Market Snapshot

    • S&P Futures

      4,215.5

    • Dow Futures

      33,347

    • Nasdaq Futures

      13,334.5

    blog search icon

    Palatin Technologies, Inc.

    (AMEX:PTN)

    $0.28

    $0.01

    2.10%

    Palatin Technologies, Inc. Chart

    PTN Stock Price Today

    Palatin Technologies, Inc. (PTN) stock rallied over 2.10% intraday to trade at $0.2819 a share on AMEX. The stock opened with a gain of 0.68% at $0.272 and touched an intraday high of $0.28, rising 4.41% against the last close of $0.27. The stock went to a low of $0.264 during the session.

    Stock Snapshot

    $0.27

    Prev. Close

    62.17 Million

    Market Cap

    $0.264

    Day Low

    $0.272

    Open

    238.81 Million

    Number of Shares

    $0.28

    Day High

    -

    P/E ratio

    -0.16

    EPS (TTM)

    0.16

    Cash Flow per Share

    0.99

    Free Float in %

    0.19

    Book Value

    712,575

    Volume

    Palatin Technologies, Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-08-10$0.272$0.28$0.264$0.276585,805
    2022-08-09$0.28$0.28$0.27$0.27454,800
    2022-08-08$0.28$0.28$0.27$0.28685,200
    2022-08-05$0.27$0.28$0.26$0.28889,100
    2022-08-04$0.27$0.28$0.26$0.271,498,700
    2022-08-03$0.27$0.27$0.25$0.271,406,400
    2022-08-02$0.27$0.27$0.27$0.27414,100
    2022-08-01$0.28$0.28$0.27$0.27748,100
    2022-07-29$0.28$0.28$0.26$0.281,316,800
    2022-07-28$0.29$0.29$0.28$0.28247,700

    Contact Details

    Cedar Brook Corporate Center
    4B Cedar Brook Drive
    Cranbury, NJ 08512
    United States

    Webiste:PTN

    609 495 2200

    Company Information

    Employees-

    Beta1.04

    Sales or Revenue872.91 Thousands

    5Y Sales Change-

    Fiscal Year Ends2021-06-29

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL3994, a natriuretic peptide receptor (NPR)-A agonist and synthetic mimetic of the endogenous neuropeptide hormone atrial natriuretic peptide for cardiovascular indications; and PL5028, an NPR-A and NPR-binder to treat cardiovascular and fibrotic diseases, including reducing cardiac hypertrophy and fibrosis. The company was incorporated in 1986 and is based in Cranbury, New Jersey.

    Frequently Asked Questions

    icon

    What is the current Palatin Technologies, Inc. (PTN) stock price?

    Palatin Technologies, Inc. (AMEX: PTN) stock price is $0.2819 as of the last check on Wednesday, August 10. During the trading session, PTN stock reached the peak price of $0.28 while $0.264 was the lowest point it dropped to.

    icon

    PTN's industry and sector of operation?

    The AMEX listed PTN is part of Biotechnology industry that operates in the broader Health Care sector. Palatin Technologies, Inc. , a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States.

    icon

    Who are the executives of PTN?

    Dr. Carl Spana Ph.D.
    Co-Founder, Pres, CEO & Director
    Mr. Stephen T. Wills CPA, CPA, MST
    CFO, COO, Exec. VP, Treasurer & Sec.
    Burns McClellan
    VP of Investor Relations
    Mr. Stephen A. Slusher Esq.
    Chief Legal Officer

    icon

    What is the PTN stock price today?

    PTN stock traded closed the last session at $0.276, which is $0.005799999999999972 or 2.1006881564650386% lower than its previous close of $0.27. PTN's current trading price is 9.65% lower than its 52-week high of $0.96 where as its distance from 52-week low of 0.25% is -71.24%.

    icon

    How many employees does PTN have?

    Number of PTN employees currently stands at -. PTN operates from Cedar Brook Corporate Center, 4B Cedar Brook Drive, Cranbury, NJ 08512, United States.

    icon

    Link for PTN official website?

    Official Webiste of $PTN is: https://palatin.com

    icon

    How do I contact PTN?

    PTN could be contacted at PTN operates from Cedar Brook Corporate Center, 4B Cedar Brook Drive, Cranbury, NJ 08512, United States, or at phone #609 495 2200 and can also be accessed through its website.

    icon

    How many shares of PTN are traded daily?

    PTN stock volume for the day was 712,575 shares while in the previous session number of PTN shares traded was 585,805 . The average number of PTN shares traded daily for last 3 months was 689.26 Thousands.

    icon

    How much did PTN change today?

    The percentage change in PTN stock occurred in the recent session was 2.1006881564650386% while the dollar amount for the price change in PTN stock was $0.005799999999999972.

    icon

    What price range PTN stock been trading in?

    In the recent session, the day high for PTN stock was $0.28 while the low for PTN stock touched on the day was $0.264.

    icon

    What is the market cap of PTN currently?

    The market value of PTN currently stands at 62.17 Million with its latest stock price at $0.2819 and 238.81 Million of its shares outstanding.